300171 Stock Overview
Tofflon Science and Technology Group Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Tofflon Science and Technology Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥12.87 |
| 52 Week High | CN¥19.81 |
| 52 Week Low | CN¥9.60 |
| Beta | 0.60 |
| 11 Month Change | 4.38% |
| 3 Month Change | 20.17% |
| 1 Year Change | -33.69% |
| 33 Year Change | -75.36% |
| 5 Year Change | 82.55% |
| Change since IPO | -23.26% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300171 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -8.9% | -5.6% | -6.7% |
| 1Y | -33.7% | -10.2% | 1.9% |
Return vs Industry: 300171 underperformed the CN Medical Equipment industry which returned -7.8% over the past year.
Return vs Market: 300171 underperformed the CN Market which returned 4% over the past year.
Price Volatility
| 300171 volatility | |
|---|---|
| 300171 Average Weekly Movement | 8.8% |
| Medical Equipment Industry Average Movement | 8.6% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CN Market | 12.5% |
| 10% least volatile stocks in CN Market | 5.5% |
Stable Share Price: 300171 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300171's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 5,716 | Xiaodong Zheng | www.tofflon.com |
Tofflon Science and Technology Group Co., Ltd. operates as a pharmaceutical equipment supplier for the pharma and biotech industries worldwide. It offers injectables, such as auto solution preparation systems, aseptic filling lines for ampoule, vials, syringes and powders, freeze dryer and auto loading systems, barrier systems, and plastic packaging machines.
Tofflon Science and Technology Group Co., Ltd. Fundamentals Summary
| 300171 fundamental statistics | |
|---|---|
| Market cap | CN¥9.79b |
| Earnings (TTM) | CN¥169.58m |
| Revenue (TTM) | CN¥4.81b |
57.7x
P/E Ratio2.0x
P/S RatioIs 300171 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300171 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.81b |
| Cost of Revenue | CN¥3.51b |
| Gross Profit | CN¥1.29b |
| Other Expenses | CN¥1.12b |
| Earnings | CN¥169.58m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.22 |
| Gross Margin | 26.91% |
| Net Profit Margin | 3.53% |
| Debt/Equity Ratio | 0.04% |
How did 300171 perform over the long term?
See historical performance and comparison